Kalray S.A. (LON:0ABT)
1.200
0.00 (0.00%)
At close: Dec 29, 2025
Kalray Revenue
Kalray had revenue of 12.73M EUR in the half year ending June 30, 2025, a decrease of -39.15%. This brings the company's revenue in the last twelve months to 38.57M, up 3.46% year-over-year. In the year 2024, Kalray had annual revenue of 44.10M with 10.38% growth.
Revenue (ttm)
38.57M EUR
Revenue Growth
+3.46%
P/S Ratio
0.43
Revenue / Employee
171.44K EUR
Employees
225
Market Cap
14.08M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.10M | 4.15M | 10.38% |
| Dec 31, 2023 | 39.95M | 9.33M | 30.45% |
| Dec 31, 2022 | 30.63M | 18.41M | 150.62% |
| Dec 31, 2021 | 12.22M | 3.61M | 41.90% |
| Dec 31, 2020 | 8.61M | 1.13M | 15.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |